The global kyphoplasty market was valued at $632.45 million in 2021, and is estimated to reach $1,154.82 million by 2031, growing at a CAGR of 6.2% from 2022 to 2031.
Kyphoplasty is a surgical procedure that expands and stabilizes spinal compression fractures. Its uses involve injecting a specific cement into vertebrae, by using a balloon-like device to create space for the procedure. Kyphoplasty is a modification of vertebroplasty that helps restore the height of a damaged vertebra as well as eases discomfort. It is one of the procedures adopted for treating vertebral body compression fractures, which are minor breaks in the dense mass of bone that makes up the front section of the spinal cord.
The major factors that drive the growth of the kyphoplasty market is the increase in geriatric population, rise in incidence of osteoporosis & arthritis, increase in the prevalence of spine disorders, and growth in patient awareness about advancements in spine surgeries, are the factors attributed to the growth of the kyphoplasty market. In addition, shift toward minimally invasive spine surgeries is a key trend of the market, which is expected to fuel the growth during the forecast period.
Significant surge in the geriatric population is one leading factors of this market as aging leads to reduced bone density, which is influenced by a variety of variables such as lifestyle, diet, physical activity (PA), smoking, alcohol use, chronic illness conditions, and medication. Aging causes a number of physiological changes that might result in illnesses like osteoporosis, thus raising the chance of bone fractures, which can lower one's quality of life. For instance, according to the International Osteoporosis Foundation, each year, osteoporosis causes more than 8.9 million fractures, with one occurring every three seconds. It affects roughly 6.3% of males over 50 and 21.2% of women in the same age range across the world, affecting approximately 500 million men and women. Thus, such high number of cases are expected to boost the kyphoplasty procedures.
In addition, upsurge in the cases of back pain, especially among women, adoption of sedentary lifestyles, lower physical activity are some risk factors that may lead to uptake of such procedures. However, unfavorable reimbursements scenarios and risks associated with post-surgical complications are expected to hinder the growth of the market. Conversely, technological advancements for minimally invasive procedures and launch of kyphoplasty products to suffice the consumer demands in developing countries is expected to provide a great opportunity for the investors to invest in the market. For instance, Medtronic in May 2020, announced the U.S. launch of Kyphon Assist Directional Cannula for use with its balloon kyphoplasty (BKP) products to treat vertebral compression fractures due to osteoporosis, cancer or benign lesions.
The global kyphoplasty market is segmented on the basis of product, indication, end user, and region. On the basis of product, the market is categorized into kyphoplasty systems and accessories. By indication, it is segmented into osteoporosis and others. By end user, it is segmented into hospital & clinics and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
The major players profiled in the report are Alphatec Holdings Inc., Benvenue Medical Inc., Globus Medical Inc., IZI Medical Products, Johnson and Johnson, Medtronic Plc., Merit Medicals Systems, Stryker Corporation, Seawon Meditech and Zimmer Biomet Holdings, Inc.
This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Region- & country-wise analysis is provided to understand the market trends and dynamics.
Kyphoplasty is a surgical procedure that expands and stabilizes spinal compression fractures. Its uses involve injecting a specific cement into vertebrae, by using a balloon-like device to create space for the procedure. Kyphoplasty is a modification of vertebroplasty that helps restore the height of a damaged vertebra as well as eases discomfort. It is one of the procedures adopted for treating vertebral body compression fractures, which are minor breaks in the dense mass of bone that makes up the front section of the spinal cord.
The major factors that drive the growth of the kyphoplasty market is the increase in geriatric population, rise in incidence of osteoporosis & arthritis, increase in the prevalence of spine disorders, and growth in patient awareness about advancements in spine surgeries, are the factors attributed to the growth of the kyphoplasty market. In addition, shift toward minimally invasive spine surgeries is a key trend of the market, which is expected to fuel the growth during the forecast period.
Significant surge in the geriatric population is one leading factors of this market as aging leads to reduced bone density, which is influenced by a variety of variables such as lifestyle, diet, physical activity (PA), smoking, alcohol use, chronic illness conditions, and medication. Aging causes a number of physiological changes that might result in illnesses like osteoporosis, thus raising the chance of bone fractures, which can lower one's quality of life. For instance, according to the International Osteoporosis Foundation, each year, osteoporosis causes more than 8.9 million fractures, with one occurring every three seconds. It affects roughly 6.3% of males over 50 and 21.2% of women in the same age range across the world, affecting approximately 500 million men and women. Thus, such high number of cases are expected to boost the kyphoplasty procedures.
In addition, upsurge in the cases of back pain, especially among women, adoption of sedentary lifestyles, lower physical activity are some risk factors that may lead to uptake of such procedures. However, unfavorable reimbursements scenarios and risks associated with post-surgical complications are expected to hinder the growth of the market. Conversely, technological advancements for minimally invasive procedures and launch of kyphoplasty products to suffice the consumer demands in developing countries is expected to provide a great opportunity for the investors to invest in the market. For instance, Medtronic in May 2020, announced the U.S. launch of Kyphon Assist Directional Cannula for use with its balloon kyphoplasty (BKP) products to treat vertebral compression fractures due to osteoporosis, cancer or benign lesions.
The global kyphoplasty market is segmented on the basis of product, indication, end user, and region. On the basis of product, the market is categorized into kyphoplasty systems and accessories. By indication, it is segmented into osteoporosis and others. By end user, it is segmented into hospital & clinics and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
The major players profiled in the report are Alphatec Holdings Inc., Benvenue Medical Inc., Globus Medical Inc., IZI Medical Products, Johnson and Johnson, Medtronic Plc., Merit Medicals Systems, Stryker Corporation, Seawon Meditech and Zimmer Biomet Holdings, Inc.
KEY BENEFITS FOR STAKEHOLDERS
This report provides an extensive analysis of the current and emerging market trends and dynamics in the global kyphoplasty market to identify the prevailing opportunities.This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Region- & country-wise analysis is provided to understand the market trends and dynamics.
Key Market Segments
By Product
- Kyphoplasty Systems
- Accessories
By Indication
- Osteoporosis
- Others
By End User
- Hospitals and Clinics
- Ambulatory Surgical Centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Alphatec Holdings TNC
- Benvenue Medical Inc
- Globul Medical Inc
- Jhonson and Jhonson
- Medtronic
- Stryker
- IZI Medica Products
- Merit Medicals Systems
- Swawon Meditech
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: KYPHOPLASTY MARKET, BY PRODUCT
CHAPTER 5: KYPHOPLASTY MARKET, BY INDICATION
CHAPTER 6: KYPHOPLASTY MARKET, BY END USER
CHAPTER 7: KYPHOPLASTY MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Kyphoplasty Market," the kyphoplasty market was valued at $632.45 million in 2021, and is estimated to reach $1.2 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031.Vertebral compression fracture (VCF) is a form of spinal disorder caused by the fracture of bones in the spinal cord as a result of osteoporosis, arthritis, or trauma. Kyphoplasty is one of the surgical options for treating this VCF. It commonly occurs in the vertebrae that have been weakened by osteoporosis or by other diseases. The fracture occurs when the bone has deteriorated to the point that it can no longer support the spine column in daily activities.
In Kyphoplasty, a needle is inserted into the spine bone via the skin. Real-time x-ray pictures help the doctor find the right spot in the lower back. A balloon is inserted into the bone through the needle; subsequently inflated and medical-grade bone cement is injected into that cavity. Bone cement, majorly consists of a liquid monomer and a copolymer powder, known as polymethylmethacrylate (PMMA). Hardening immediately, the cavity becomes stabilized by the substance. Thus, the height of the vertebrae is restored to prevent it from collapsing again. It is a generally safe procedure for restoring spinal height, correcting kyphosis deformity, and removing compression fracture discomfort.
Increase in the elderly population, surge in cases of osteoporosis & arthritis, and spine disorders are the major drivers of this market. Kyphoplasty is performed in cancer-damaged vertebrae, some spinal fractures, and also due to long-term steroid treatment or a metabolic disorder. In addition, it is a minimally invasive low risk procedure and has a short recovery time making it the safest treatment for VCF. In addition, higher adoption rate of sedentary lifestyles, loss of physical activity especially among aging individuals, upsurge in accidents and trauma increases chances of having Kyphoplasty. Furthermore, innovations, development of advanced technologies, key strategies adopted by the key players and increasing awareness for spinal treatments kyphoplasty market trends. However, post-surgery complications such as cement leakage, are expected to hinder the kyphoplasty industry growth. Conversely, increase in spinal disease load and rise in healthcare expenditure are great opportunities for key players to invest during the forecast period, especially in the developing economies.
By product, the market is segmented into kyphoplasty systems and accessories. The accessories segment generated maximum revenue in 2021, owing to increase in the demand for bone cements, biopsy kits due to surge in the bone cancer cases. The kyphoplasty systems segment is expected to witness highest CAGR of 6.6% during the forecast period, owing to various developments and launch of products such as the balloon inflation devices and bone access devices.
Depending on indication, the market is divided into osteoporosis and others. The osteoporosis segment kyphoplasty market share in 2021, owing to increase in geriatric population, which is more prone to osteoporosis. The others segment is expected to witness highest CAGR of 7.2% during the forecast period, owing to surge in the road accidents, sports injuries and cancer cases among the population.
Depending on end user, the market is divided into hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment dominated the market in 2021, with $494.84 million, owing to increase in number of hospital admissions for vertebral compression fractures and accidental injuries to spinal cord. The ambulatory surgical centers segment is expected to witness highest kyphoplasty market growth during the forecast period, owing to surge in osteoporosis diagnosis and demand for ASCs, owing to its specific care and comfortable settings for elderly.
North America accounted for a majority of the global kyphoplasty market size in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to technological advancements in kyphoplasty techniques, integration of advanced devices and software processes in kyphoplasty devices, presence of key and robust hospital infrastructure in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in geriatric population, development of healthcare infrastructure and increase in investments projects in the region.
Key Findings of the Study
- By product, the accessories segment was the highest contributor to the market in 2021, and is expected to continue this trend during the forecast period.
- By indication, osteoporosis segment was the highest contributor to the market in 2021, and is expected to continue this trend during the forecast period.
- Depending on end user, the hospital & clinics segment was highest contributor in 2021, and is expected to continue this trend during the forecast period.
- Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Alphatec Holdings Tnc
- Benvenue Medical Inc
- Globul Medical Inc
- Jhonson and Jhonson
- Medtronic
- Stryker
- Izi Medica Products
- Merit Medicals Systems
- Swawon Meditech
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | June 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 632.45 million |
| Forecasted Market Value ( USD | $ 1154.82 million |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
